MS Stock Analysis: Morgan Stanley | NYSE

Capital Markets | NYSE, USA | Market Cap: 297.994m USD | 12M Return: 19% | US6174464486 | Charts, Fundamentals & Technical Analysis

Banking, Wealth Management, Asset Management, Securities Trading
Total Rating 31
Safety 33
Buy Signal -0.38
Investment Banking & Brokerage
Sub-Industry Rotation: +3.4
Market Cap: 298B
Avg Turnover: 1.13B
Risk 3d forecast
Volatility34.7%
VaR 5th Pctl5.86%
VaR vs Median2.77%
Reward TTM
Sharpe Ratio0.51
Rel. Str. IBD40.6
Rel. Str. Peer Group72.1 pctl
Character TTM
Beta1.482
Beta Downside1.409
Hurst Exponent0.401
Choppyness47.9%
Drawdowns 3y
Max DD29.24%
CAGR/Max DD1.26
CAGR/Mean DD6.69
EPS (Earnings per Share) EPS (Earnings per Share) of MS over the last years for every Quarter: "2021-09": 2.04, "2021-12": 2.08, "2022-03": 2.06, "2022-06": 1.53, "2022-09": 1.47, "2022-12": 1.31, "2023-03": 1.74, "2023-06": 1.44, "2023-09": 1.38, "2023-12": 0.85, "2024-03": 2.02, "2024-06": 1.82, "2024-09": 1.88, "2024-12": 2.22, "2025-03": 2.6, "2025-06": 2.13, "2025-09": 2.8, "2025-12": 2.68, "2026-03": 3.43, "2026-06": 3.46, "2026-09": 3.03,
EPS CAGR: 38.59%
EPS Trend: 99.2%
Last SUE: 1.10
Qual. Beats: 5
Revenue Revenue of MS over the last years for every Quarter: 2021-09: 14216, 2021-12: 14035, 2022-03: 14353, 2022-06: 13584, 2022-09: 15730, 2022-12: 18811, 2023-03: 21270, 2023-06: 21485, 2023-09: 22567, 2023-12: 24192, 2024-03: 25349, 2024-06: 25486, 2024-09: 26328, 2024-12: 25982, 2025-03: 27912, 2025-06: 28162, 2025-09: 30048, 2025-12: 28861, 2026-03: 33150, 2026-06: 34470, 2026-09: 33276,
Rev. CAGR: 13.67%
Rev. Trend: 99.5%
Last SUE: 0.92
Qual. Beats: 6

Warnings

Below Avwap Earnings
Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 11.9 years of data, until 10/2026

Jan -0.1% 0
Feb -1.7% 14
Mar -2.9% 28
Apr +2.0% 4
May +2.5% 4
Jun -0.1% 0
Jul +1.0% 4
Aug -0.7% 4
Sep -4.3% 28
Oct +2.3% 14
Nov +4.2% 21
Dec +0.2% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: MS Morgan Stanley

Morgan Stanley (NYSE: MS) is a global financial holding company headquartered in New York, founded in 1924 and listed since 1993. It operates through three core segments: Institutional Securities, Wealth Management, and Investment Management, serving corporations, governments, financial institutions, and individuals across the Americas, Asia, Europe, the Middle East, and Africa. Within the Financials sector, the firm is classified under the Investment Banking & Brokerage sub-industry, reflecting its roots and continued emphasis on capital markets activity alongside its growing asset and wealth management franchises.

The Institutional Securities segment encompasses the firms investment banking and capital markets businesses, including equity and fixed income underwriting, mergers and acquisitions advisory, restructurings, and project finance. It also covers sales, financing, prime brokerage, and market-making activities, as well as corporate and commercial real estate lending, securities-based financing, and research. This segment reflects the traditional investment banking model, in which advisory fees, underwriting spreads, and trading revenues are the primary drivers of earnings.

The Wealth Management segment serves individual investors and intermediaries through financial advisor-led brokerage, self-directed brokerage, investment advisory, custody, cash management, banking, retirement plan services, and lending products such as residential real estate and securities-based loans. The Investment Management segment provides equity, fixed income, alternatives, solutions, and liquidity and overlay services to institutional and individual clients, including pension plans, foundations, endowments, sovereign wealth funds, and insurance companies. Together, these two segments anchor the firms recurring fee-based revenue model, complementing the more cyclical performance of its institutional securities business.

Headlines to Watch Out For
  • Wealth Management fee revenues grow on expanding advisor-led AUM
  • Investment banking advisory revenue rises on M&A recovery
  • Net interest income moves with Fed rate cuts
Piotroski VR-10 (Strict) 2.5
Net Income: 20.5b TTM > 0 and > 6% of Revenue
FCF/TA: -0.03 > 0.02 and ΔFCF/TA -2.97 > 1.0
NWC/Revenue: -276.1% < 20% (prev -556.6%; Δ 280.5% < -1%)
CFO/TA -0.03 > 3% & CFO -58.3b > Net Income 20.5b
Net Debt (410b) to EBITDA (30.8b): 13.29 < 3
Current Ratio: 0.25 > 1.5 & < 3
Outstanding Shares: last quarter (1.57b) vs 12m ago -1.41% < -2%
Gross Margin: 60.63% > 18% (prev 56.91%; Δ 3.71% > 0.5%)
Asset Turnover: 8.49% > 50% (prev 8.21%; Δ 0.28% > 0%)
Interest Coverage Ratio: 0.53 > 6 (EBIT TTM 26.6b / Interest Expense TTM 50.7b)
Altman Z'' -0.94
A: -0.21 (Total Current Assets 120b - Total Current Liabilities 478b) / Total Assets 1692b
B: 0.07 (Retained Earnings 126b / Total Assets 1692b)
C: 0.02 (EBIT TTM 26.6b / Avg Total Assets 1529b)
D: 0.09 (Book Value of Equity 117b / Total Liabilities 1308b)
Altman-Z'' = -0.94 = CCC
Beneish M -1.76
DSRI: 2.39 (Receivables 313b/113b, Revenue 130b/112b)
GMI: 0.94 (GM 56.91% / 60.63%)
AQI: 1.11 (AQ_t 0.93 / AQ_t-1 0.84)
SGI: 1.16 (Revenue 130b / 112b)
TATA: 0.05 (NI 20.5b - CFO -58.3b) / TA 1692b)
Beneish M = -1.76 (Cap -4..+1) = CCC
What is the price of MS shares?

As of November 17, 2026, the stock is trading at USD 185.57 with a total of 5,675,574 shares traded. Over the past week, the price has changed by -0.82%, over one month by +3.39%, over three months by -14.44% and over the past year by +19.02%.

Current recommended Stop Loss: 178.50 (which is 3.8% or 1.3 ATR below the current price).

Is MS a buy, sell or hold?

Morgan Stanley has received a consensus analysts rating of 3.69. Therefore, it is recommended to hold MS.

  • StrongBuy: 9
  • Buy: 2
  • Hold: 14
  • Sell: 0
  • StrongSell: 1

What are the forecasts/targets for the MS price?
Analysts Target Price 211.5 14%
Morgan Stanley (MS) - Fundamental Data Overview as of 14 November 2026
Market Cap USD = 298b (298b USD * 1.0 USD.USD)
P/E Trailing = 15.119
P/E Forward = 13.8313
P/S = 3.7345
P/B = 2.7541
P/EG = 1.6456
Revenue TTM = 130b USD
EBIT TTM = 26.6b USD
EBITDA TTM = 30.8b USD
Long Term Debt = 387b USD (from longTermDebt, last quarter)
Short Term Debt = 143b USD (from shortTermDebt, last quarter)
Debt = 530b USD (corrected: LT Debt 387b + ST Debt 143b)
Net Debt = 410b USD (calculated: Debt 530b - CCE 120b)
Enterprise Value = 708b USD (298b + Debt 530b - CCE 120b)
Interest Coverage Ratio = 0.53 (Ebit TTM 26.6b / Interest Expense TTM 50.7b)
EV/FCF = -12.07x (Enterprise Value 708b / FCF TTM -58.6b)
FCF Yield = -8.28% (FCF TTM -58.6b / Enterprise Value 708b)
FCF Margin = -45.17% (FCF TTM -58.6b / Revenue TTM 130b)
Net Margin = 15.82% (Net Income TTM 20.5b / Revenue TTM 130b)
Gross Margin = 60.63% ((Revenue TTM 130b - Cost of Revenue TTM 51.1b) / Revenue TTM)
Gross Margin QoQ = 60.67% (prev 61.65%)
Tobins Q-Ratio = 0.42 (Enterprise Value 708b / Total Assets 1692b)
Interest Expense / Debt = 9.58% (Interest Expense 50.7b / Debt 530b)
Taxrate = 22.23% (5.91b / 26.6b)
NOPAT = 20.7b (EBIT 26.6b * (1 - 22.23%))
Current Ratio = 0.25 (Total Current Assets 120b / Total Current Liabilities 478b)
Debt / Equity = 4.51 (Debt 530b / totalStockholderEquity, last quarter 117b)
Debt / EBITDA = 13.29 (Net Debt 410b / EBITDA 30.8b)
 Debt / FCF = -6.99 (negative FCF - burning cash) (Net Debt 410b / FCF TTM -58.6b)
 Total Stockholder Equity = 115b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.34% (Net Income 20.5b / Total Assets 1692b)
RoE = 17.86% (Net Income TTM 20.5b / Total Stockholder Equity 115b)
RoCE = 5.31% (EBIT 26.6b / Capital Employed (Equity 115b + L.T.Debt 387b))
RoIC = 1.53% (NOPAT 20.7b / Invested Capital 1350b)
WACC = 8.59% (E(298b)/V(828b) * Re(10.61%) + D(530b)/V(828b) * Rd(9.58%) * (1-Tc(0.22)))
Discount Rate = 10.61% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -89.24 | Cagr: -1.12%
 [DCF] Fair Price = unknown (Cash Flow -58.6b)
 EPS Correlation: 99.25 | EPS CAGR: 38.59% | SUE: 1.10 | # QB: 5
Revenue Correlation: 99.52 | Revenue CAGR: 13.67% | SUE: 0.92 | # QB: 6
EPS current Quarter (2027-03-31): EPS=3.59 | Chg30d=-2.43% | Revisions=-36% | Analysts=10
EPS current Year (2026-12-31): EPS=12.91 | Chg30d=+1.65% | Revisions=+0% | GrowthEPS=+26.4% | GrowthRev=+16.8%
EPS next Year (2027-12-31): EPS=13.69 | Chg30d=+0.46% | Revisions=+19% | GrowthEPS=+6.1% | GrowthRev=+5.0%
[Analyst] Revisions Ratio: +0% (up=23, down=23)